Literature DB >> 21815997

CDH13 is associated with working memory performance in attention deficit/hyperactivity disorder.

A Arias-Vásquez1, M E Altink, N N J Rommelse, D I E Slaats-Willemse, C J M Buschgens, E A Fliers, S V Faraone, J A Sergeant, J Oosterlaan, B Franke, J K Buitelaar.   

Abstract

Different analytic strategies, including linkage, association and meta-analysis support a role of CDH13 in the susceptibility to attention deficit/hyperactivity disorder (ADHD). CDH13 codes for cadherin 13 (or H-cadherin), which is a member of a family of calcium-dependent cell-cell adhesion proteins and a regulator of neural cell growth. We tested the association between CDH13 on three executive functioning tasks that are promising endophenotypes of ADHD. An adjusted linear regression analysis was performed in 190 ADHD-affected Dutch probands of the IMAGE project. Three executive functions were examined: inhibition, verbal and visuo-spatial working memory (WM). We tested 2632 single nucleotide polymorphisms (SNPs) within CDH13 and 20 kb up- and downstream of the gene (capturing regulatory sequences). To adjust for multiple testing within the gene, we applied stringent permutation steps. Intronic SNP rs11150556 is associated with performance on the Verbal WM task. No other SNP showed gene-wide significance with any of the analyzed traits, but a 72-kb SNP block located 446 kb upstream of SNP rs111500556 showed suggestive evidence for association (P-value range 1.20E-03 to 1.73E-04) with performance in the same Verbal WM task. This study is the first to examine CDH13 and neurocognitive functioning. The mechanisms underlying the associations between CDH13 and the clinical phenotype of ADHD and verbal WM are still unknown. As such, our study may be viewed as exploratory, with the results presented providing interesting hypotheses for further testing.
© 2011 The Authors. Genes, Brain and Behavior © 2011 Blackwell Publishing Ltd and International Behavioural and Neural Genetics Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21815997     DOI: 10.1111/j.1601-183X.2011.00724.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  24 in total

1.  Neuropsychological and dimensional behavioral trait profiles in Costa Rican ADHD sib pairs: Potential intermediate phenotypes for genetic studies.

Authors:  Viviana A Peskin; Anna Ordóñez; R Scott Mackin; Kevin Delucchi; Silvia Monge; James J McGough; Denise A Chavira; Monica Berrocal; Erika Cheung; Eduardo Fournier; Judith A Badner; Luis Diego Herrera; Carol A Mathews
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-03-31       Impact factor: 3.568

2.  Heterozygous deletion of the LRFN2 gene is associated with working memory deficits.

Authors:  Julien Thevenon; Céline Souchay; Gail K Seabold; Inna Dygai-Cochet; Patrick Callier; Sébastien Gay; Lucie Corbin; Laurence Duplomb; Christel Thauvin-Robinet; Alice Masurel-Paulet; Salima El Chehadeh; Magali Avila; Delphine Minot; Eric Guedj; Sophie Chancenotte; Marlène Bonnet; Daphne Lehalle; Ya-Xian Wang; Paul Kuentz; Frédéric Huet; Anne-Laure Mosca-Boidron; Nathalie Marle; Ronald S Petralia; Laurence Faivre
Journal:  Eur J Hum Genet       Date:  2015-10-21       Impact factor: 4.246

3.  Genetic background of extreme violent behavior.

Authors:  J Tiihonen; M-R Rautiainen; H M Ollila; E Repo-Tiihonen; M Virkkunen; A Palotie; O Pietiläinen; K Kristiansson; M Joukamaa; H Lauerma; J Saarela; S Tyni; H Vartiainen; J Paananen; D Goldman; T Paunio
Journal:  Mol Psychiatry       Date:  2014-10-28       Impact factor: 15.992

4.  The Gain-of-Function Integrin β3 Pro33 Variant Alters the Serotonin System in the Mouse Brain.

Authors:  Michael R Dohn; Christopher G Kooker; Lisa Bastarache; Tammy Jessen; Capria Rinaldi; Seth Varney; Matthew D Mazalouskas; Hope Pan; Kendra H Oliver; Digna R Velez Edwards; James S Sutcliffe; Joshua C Denny; Ana M D Carneiro
Journal:  J Neurosci       Date:  2017-10-16       Impact factor: 6.167

5.  Pharmacogenetics of stimulant abuse liability: association of CDH13 variant with amphetamine response in a racially-heterogeneous sample of healthy young adults.

Authors:  Adam M Leventhal; Matthew G Kirkpatrick; Mollie S Pester; John E McGeary; Robert M Swift; Steve Sussman; Christopher W Kahler
Journal:  Psychopharmacology (Berl)       Date:  2016-10-22       Impact factor: 4.530

6.  Cadherin 13: human cis-regulation and selectively-altered addiction phenotypes and cerebral cortical dopamine in knockout mice.

Authors:  Jana Drgonova; Donna Walther; G Luke Hartstein; Mohammad O Bukhari; Michael H Baumann; Jonathan Katz; Frank Scott Hall; Elizabeth R Arnold; Shaun Flax; Anthony Riley; Olga Rivero-Martin; Klaus-Peter Lesch; Juan Troncoso; Barbara Ranscht; George R Uhl
Journal:  Mol Med       Date:  2016-08-18       Impact factor: 6.354

Review 7.  Moving towards causality in attention-deficit hyperactivity disorder: overview of neural and genetic mechanisms.

Authors:  Eduardo F Gallo; Jonathan Posner
Journal:  Lancet Psychiatry       Date:  2016-05-13       Impact factor: 27.083

8.  CDH13 and LPHN3 Gene Polymorphisms in Attention-Deficit/Hyperactivity Disorder: Their Relation to Clinical Characteristics.

Authors:  Ahmet Özaslan; Esra Güney; Mehmet Ali Ergün; İlyas Okur; Dilek Yapar
Journal:  J Mol Neurosci       Date:  2020-07-20       Impact factor: 3.444

9.  High resolution whole brain imaging of anatomical variation in XO, XX, and XY mice.

Authors:  Armin Raznahan; Frank Probst; Mark R Palmert; Jay N Giedd; Jason P Lerch
Journal:  Neuroimage       Date:  2013-07-25       Impact factor: 6.556

10.  MAP1B and NOS1 genes are associated with working memory in youths with attention-deficit/hyperactivity disorder.

Authors:  Angélica Salatino-Oliveira; Flávia Wagner; Glaucia C Akutagava-Martins; Estela M Bruxel; Júlia P Genro; Cristian Zeni; Christian Kieling; Guilherme V Polanczyk; Luis A Rohde; Mara H Hutz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-08-02       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.